Jose de la Torre, MD
Physical Medicine & Rehabilitation · Wesley Chapel, FLNPI 1881699577
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $20,162 of the $23,163 with a category attached, or 87.0%. It is spread thinly across 54 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 944 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- AbbVie$3K
- Boston Scientific$2K
- Abbott$2K
- Medtronic$2K
- Collegium Pharmaceutical, Inc.$1K
- plus $10K from 48 others
Across 1 payment — averaging $400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atland Pharmaceuticals, LLC$400
What the payments were for
- Travel & lodging$2,95813%
- Food & beverage$20,16287%
- Education$210%
- Entertainment$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,579
- SYNCHROMED$988
- IFUSE IMPLANT SYSTEM$567
- PROCLAIM$373
- WaveWriter Alpha Prime 16$285
- Reltone 200 Mg$283
- GLYCATE$283
- Reltone 400 Mg$283
- ALLODERM$275
- PAINTEQ$244
- AIMOVIG$241
- NURTEC ODT$219
- Intracept RF Probe$164
- Proclaim Family of SCS IPGs$161
- Dynasplint$156
- ETERNA$155
- OCTRODE$139
- NATRELLE$139
- Evoke SCS$137
How this compares
$23,163 in reported general payments places this provider in the 95th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 34 | $67,170 |
| Xtampza ErOxycodone Myristate | 123 | $56,230 |
| Nucynta ErTapentadol Hcl | 31 | $56,082 |
| UbrelvyUbrogepant | 35 | $47,674 |
| BelbucaBuprenorphine Hcl | 37 | $27,858 |
| RelistorMethylnaltrexone Bromide | 11 | $27,797 |
| Emgality PenGalcanezumab-Gnlm | 35 | $27,116 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 120 | $26,150 |
| Oxymorphone Hcl ErOxymorphone Hcl | 13 | $24,423 |
| NucyntaTapentadol Hcl | 21 | $21,687 |
| Oxycodone Hcl | 567 | $19,907 |
| QuliptaAtogepant | 18 | $19,782 |
| BotoxOnabotulinumtoxina | 15 | $19,377 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 357 | $14,018 |
| Fentanyl | 59 | $13,139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca, Nucynta | $1,415 | $161,858212 claims |
| AbbVieUbrelvy, Qulipta, Botox | $3,240 | $86,83368 claims |
| PfizerNurtec Odt | $1,019 | $67,17034 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl | $33 | $31,856176 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $409 | $27,79711 claims |
| Indivior Inc.Suboxone | $285 | $11,12015 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $796 | $9,57921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 618 physical medicine & rehabilitation providers in Florida.
Other physical medicine & rehabilitation in Wesley Chapel
- Anthony GiuffridaFort Lauderdale$271K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
- Jose Medina SanchezTampa$30K
- Alan MillerFernandina Beach$26K
- Anish SoniNaples$25K
- Kaivalya DeshpandeMiami$22K
- Ryan RamsookTallahassee$21K
- James AtchisonJacksonville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.